医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集
▼×

疾病

Aptorum Group [APM] to Ring the NASDAQ Stock Market Closing Bell in Celebration of IPO Closing

Aptorum Group [APM] to Ring the NASDAQ Stock Market Closing Bell in Celebration of IPO Closing

ヘルスケア外科感染症腫瘍学臨床試験製薬　 TimeLine: Aptorum Group Celebration of IPO Closing to Ring the NASDAQ Stock Market Closing

2018年12月18日

0

Aptorum Group Limited Announces Closing of Initial Public Offering

Aptorum Group Limited Announces Closing of Initial Public Offering

バイオテクノロジーヘルスケア感染症腫瘍学製薬　 TimeLine: Aptorum Group Limited Announces Closing of Initial

2018年12月18日

0

CDISC and Cohen Veterans Bioscience Announce Release of First Data Standard to Improve Research for Post Traumatic Stress Disorder

CDISC and Cohen Veterans Bioscience Announce Release of First Data Standard to Improve Research for Post Traumatic Stress Disorder

その他ヘルスバイオテクノロジーヘルスケアメンタルヘルス　 TimeLine: CDISC and Cohen Veterans Bioscience Announce Standard to Improve Research for Post Traumatic

2018年12月13日

0

Aptorum Group Limited Announces Pricing of Initial Public Offering

Aptorum Group Limited Announces Pricing of Initial Public Offering

その他ヘルスバイオテクノロジーヘルスケア感染症腫瘍学製薬　 TimeLine: Aptorum Group Limited Announces Pricing of Initial

2018年12月07日

0

Brii Biosciences Builds Innovative Pipeline, Forges Public-Private Partnerships to Bring Novel Medicines to Chinese Patients

Brii Biosciences Builds Innovative Pipeline, Forges Public-Private Partnerships to Bring Novel Medicines to Chinese Patients

バイオテクノロジーヘルスケア感染症臨床試験製薬　 TimeLine: Brii Biosciences Builds Innovative Pipeline Forges Public-Private Partnerships to Bring Novel Medicines to Chinese

2018年12月06日

0

China National Medical Products Administration Approves Descovy® (Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 Infection

China National Medical Products Administration Approves Descovy® (Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 Infection

AIDS バイオテクノロジーヘルスケア病院臨床試験製薬　 TimeLine: China National Medical Products Administration for the Treatment of HIV-1 Tenofovir Alafenamide

2018年12月04日

0

Hong Kong High Court Issues Declaratory Orders and Permanent Injunctive Relief in Favor of Sinovac’s Biotech Ltd. Senior Management

Hong Kong High Court Issues Declaratory Orders and Permanent Injunctive Relief in Favor of Sinovac’s Biotech Ltd. Senior Management

バイオテクノロジーヘルスケア感染症製薬　 TimeLine: Hong Kong High Court Issues Declaratory Orders Injunctive Relief in Favor of Sinovac's Biotech

2018年11月29日

0

Celltrion and Teva Announce FDA Approval of TRUXIMA® (rituximab-abbs), a Biosimilar to RITUXAN®, for Three Non-Hodgkin’s Lymphoma Indications

Celltrion and Teva Announce FDA Approval of TRUXIMA® (rituximab-abbs), a Biosimilar to RITUXAN®, for Three Non-Hodgkin’s Lymphoma Indications

バイオテクノロジーヘルスケアマネージド・ケア感染症腫瘍学臨床試験製薬　 TimeLine: a Biosimilar to RITUXAN Celltrion and Teva Announce FDA Approval rituximab-abbs Three Non-Hodgkin's Lymphoma Indications

2018年11月29日

0

GI Dynamics Announces Agreement with Apollo Sugar to Study EndoBarrier in India

GI Dynamics Announces Agreement with Apollo Sugar to Study EndoBarrier in India

バイオテクノロジーヘルスケア医療機器糖尿病臨床試験製薬　 TimeLine: GI Dynamics Announces Agreement with Apollo Sugar

2018年11月28日

0

Final Patient Enrolled in Landmark Alzheimer’s Treatment Trial Targeting Stress Hormone Cortisol

Final Patient Enrolled in Landmark Alzheimer’s Treatment Trial Targeting Stress Hormone Cortisol

その他ヘルスバイオテクノロジーヘルスケアメンタルヘルス臨床試験製薬　 TimeLine: Final Patient Enrolled in Landmark Alzheimer's Targeting Stress Hormone Cortisol

2018年11月26日

0